Silent Pressure: Outcomes Of As-Needed Antihypertensives In Hospitalized Adults*,
2025
Parkview Health
Silent Pressure: Outcomes Of As-Needed Antihypertensives In Hospitalized Adults*, Corey Uetrecht Pharmd Candidate
Pharmacy Residency
Presented at ACCP
This study found that PRN antihypertensives are frequently used for AEBP in hospitalized patients, despite limited benefit and potential risk of hypotension-related adverse events.
Evaluation Of A Pharmacist-Driven Electrolyte Replacement Protocol In A Community Health System,
2025
Parkview Health
Evaluation Of A Pharmacist-Driven Electrolyte Replacement Protocol In A Community Health System, Corey Uetrecht Pharmd Candidate
Pharmacy Residency
This evaluation found a higher rate of pharmacist consults for electrolyte management, though these were not always indicated. Repletion via oral route was not optimized and there were opportunities for improvement in protocol alignment.
Presented at Great Lakes PRC
Implementation Of An Evidence Based Skin And Soft Tissue Infection Algorithm At A Large Community Health System,
2025
Parkview Health
Implementation Of An Evidence Based Skin And Soft Tissue Infection Algorithm At A Large Community Health System, Jennifer Mccarthy Pharmd, Ms
Pharmacy Residency
This study found a continued need for an updated skin and soft tissue infection algorithm. Ongoing reliance on IV antibiotics suggests underutilization of oral options. Promoting oral antibiotic use may reduce inpatient admissions and length of stay.
Presented at OHIO PRC
Development And Implementation Of An Analgesia, Sedation, And Paralysis Order Panel For Mechanically Ventilated Pediatric Patients At A Large Community Health System,
2025
Parkview Health
Development And Implementation Of An Analgesia, Sedation, And Paralysis Order Panel For Mechanically Ventilated Pediatric Patients At A Large Community Health System, Kristin Lytal Pharmd, Mspgx
Pharmacy Residency
This project describes best practices and steps taken in development of a protocol for analgesia, sedation, and paralysis in pediatric patients.
This was presented at OHIO PRC.
Hypertensive Hijinks: Implementation Of An Emergency Department Hypertensive Emergency Order Panel,
2025
Parkview Health
Hypertensive Hijinks: Implementation Of An Emergency Department Hypertensive Emergency Order Panel, Caleb Hoppe Pharmd Candidate
Pharmacy Residency
This evaluation found that the order panel was effective in promoting rapid blood pressure attainment and appropriate antihypertensive dosing.
This was presented at the OHIO PRC.
Evaluating The Impact Of A Pharmacist-Led Wellness And Weight Management (Wwm) Service In The Primary Care Setting,
2025
Parkview Health
Evaluating The Impact Of A Pharmacist-Led Wellness And Weight Management (Wwm) Service In The Primary Care Setting, Nicholas Buttermore Pharmd
Pharmacy Residency
This evaluation found superior weight loss from baseline with pharmacist management, along with comparable GLP-1 and non-GLP-1 use and considerable financial benefits.
Evaluating A Clinical Pharmacist's Role In An Internal Medicine Graduate Medical Education Primary Care Residency Clinic,
2025
Parkview Health
Evaluating A Clinical Pharmacist's Role In An Internal Medicine Graduate Medical Education Primary Care Residency Clinic, Le Thien Truc Pham Pharmd
Pharmacy Residency
Presented at the Midyear Clinical Meeting
Approximately 98% of all survey participants were satisfied with the clinical pharmacy services. Diabetes management was found to be the most valuable pharmacy service.
Catch Flights, Not Rsv: Real-World Evaluation Of Respiratory Syncytial Virus (Rsv) Vaccine Use In Maternal And Older Adult Populations,
2025
Parkview Health
Catch Flights, Not Rsv: Real-World Evaluation Of Respiratory Syncytial Virus (Rsv) Vaccine Use In Maternal And Older Adult Populations, Afamefuna Nzekwe
Pharmacy Residency
Present at the Midyear Clinical Meeting.
This evaluation found that most vaccinated patients met criteria. About 1/3 of newborns received RSV protection, but post-birth nirsevimab use could not be confirmed for non-Parkview patients.
Evaluation Of Corticosteroid Use In Pediatric Patients With Bronchiolitis,
2025
Parkview Health
Evaluation Of Corticosteroid Use In Pediatric Patients With Bronchiolitis, Kaitlyn Margraf Pharmd
Pharmacy Residency
Presented at Midyear Clinical Meeting.
Nearly 67% of pediatric patients treated for bronchiolitis received steroids with no underlying indication, which deviates from clinical guidelines. Patients who received steroids without an indication had an apparent trend toward more oxygen support and had an increase in maximum flow rate compared to patients with an indication for steroid use.
Effects Of Cross-Sex Hormone Therapy (Csht) On Aortic Reactivity And Metabolic Parameters In Gonadectomized Male And Female Rats,
2025
University of the Pacific
Effects Of Cross-Sex Hormone Therapy (Csht) On Aortic Reactivity And Metabolic Parameters In Gonadectomized Male And Female Rats, Rifat Ara Islam
University of the Pacific Theses and Dissertations
With the rising awareness, the number of individuals identifying themselves as transgender in the US is increasing over the years. Cross-sex hormone therapy (CSHT) may alter cardiometabolic parameters leading to the increased risk of cardiovascular diseases (CVD) in transgender population. However, the underlying mechanisms of impaired cardiovascular functions in transgender female (male to female, MtF) or transgender male (female to male, FtM) individuals are not well documented. This study was undertaken to examine the effects of 17β-estradiol (E2)- and testosterone propionate (Tes)-treatment on key cardiometabolic parameters and aortic reactivity in castrated (CAS) male and ovariectomized (OVX) female Sprague Dawley (SD) …
Sharksrx Newsletter Spring 2025,
2025
Nova Southeastern University
Sharksrx Newsletter Spring 2025, Nova Southeastern University
NSU Sharks Rx
No abstract provided.
Research News, Publications, 2025, Volume 4,
2025
School of Pharmacy, University of Mississippi
Research News, Publications, 2025, Volume 4, Soumyajit Majumdar
Publications (2015-)
Publications that appeared during the period of October 1 - December 31, 2025.
Research News, Publications, 2025, Volume 3,
2025
School of Pharmacy, University of Mississippi
Research News, Publications, 2025, Volume 3, Soumyajit Majumdar
Publications (2015-)
Publications that appeared during the period of July 1 - September 30, 2025.
Research News, Publications, 2025, Volume 2,
2025
School of Pharmacy, University of Mississippi
Research News, Publications, 2025, Volume 2, Soumyajit Majumdar
Publications (2015-)
Publications that appeared during the period of April 1 - June 30, 2025.
Impact Of Tetrahydrocannabinol (Thc) On Daphnia Magna Heart Rate,
2025
The University of Akron
Impact Of Tetrahydrocannabinol (Thc) On Daphnia Magna Heart Rate, Ashley Cosgrave
Williams Honors College, Honors Research Projects
Marijuana (Cannabis) is currently federally illegal within the United States and classified as a Schedule I drug. This leaves a large research gap on the impacts of Tetrahydrocannabinol (THC) use. Daphnia magna are frequently used as a model organism for the human heart and toxicology screenings due to their myogenic heart, similarities in physiological pathways, and sensitivity to toxins. As such, in order to bridge the research gap and uncover potential use of Daphnia magna as a model organism for humans in regard to impact on heart rate, we hypothesized that if Daphnia magna possess CB1 receptors or an equivalent …
Formulation And Immunogenicity Of L1 Orf1 Mrna Vaccine In Mice,
2025
South Dakota State University
Formulation And Immunogenicity Of L1 Orf1 Mrna Vaccine In Mice, Raj Nandani
Electronic Theses and Dissertations
This dissertation presents the design, formulation, and immunogenicity evaluation of a novel mRNA vaccine targeting the L1 ORF1p protein, a tumor-associated antigen. The vaccine was synthesized using in vitro transcription and encapsulated in lipid nanoparticles (LNPs), with both unmodified uridine and N1-methylpseudouridine variants tested. Physicochemical characterization confirmed optimal particle size (160–220 nm), acceptable zeta potential, and encapsulation efficiency ranging from 74% to 92%, with preserved RNA integrity post-formulation. These results validate the robustness of the formulation workflow and its suitability for antigen delivery. Immunogenicity studies in C57BL/6 mice revealed modest but promising immune responses. While early activation markers (CD69) and …
Exosomes And Encapsulated Exomirs In Breast Cancer: Theragnostic Applications And Clinical Implications,
2025
University of Central Punjab
Exosomes And Encapsulated Exomirs In Breast Cancer: Theragnostic Applications And Clinical Implications, Muhammad Imran Sajid, Shafia Bukhari, Hamid Ilyas, Rubina Malik, Minahil Fatima, Rakesh Kumar Tiwari, Surya M. Nauli, Khawaja Husnain Haider
Pharmacy Faculty Books and Book Chapters
Exosomes, released by cells, are small vesicles that have emerged as critical theranostic tools in breast cancer due to their unique ability to transport diverse biomolecules such as proteins, lipids, and RNAs, including microRNAs (ExomiRs). These vesicles are critical in modulating the tumor microenvironment, driving processes like cancer proliferation, invasion, metastasis, and drug resistance. Exosomal microRNAs such as ExomiR-21, ExomiR-1246, and ExomiR-155, with their profound influence on the gene expressions in the recipient cells, are the unsung heroes in tumor progression and immune modulation. This chapter delves into exosome's dual diagnostic and therapeutic potential in breast cancer. It highlights their …
The Future Of Ai Regulation In Drug Development: A Comparative Analysis,
2025
Duke Law School
The Future Of Ai Regulation In Drug Development: A Comparative Analysis, Gabriela Lenarczyk, Timo Minssen, Nicholson Price, Arti Rai
Faculty Scholarship
As artificial intelligence (AI) transforms drug development, regulatory frameworks are evolving to oversee its implementation, particularly at the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This paper makes three contributions to understanding emerging regulatory approaches. First, we offer a comparative analysis of how these agencies have responded to AI-driven advances, incorporating new US executive orders and the European Union (EU)’s AI Act. Second, we propose a novel analytical framework to understand regulatory divergence: the FDA’s flexible, dialog-driven model contrasts with the EMA’s structured, risk-tiered approach, reflecting broader institutional and political-economic differences. While the former encourages …
Research News, Grants, 2025, Volume 2,
2025
School of Pharmacy, University of Mississippi
Research News, Grants, 2025, Volume 2, Soumyajit Majumdar
Grants (2015-)
Grants and contracts awarded during April - June 2025.
Research News, Grants, 2025, Volume 4,
2025
School of Pharmacy, University of Mississippi
Research News, Grants, 2025, Volume 4, Soumyajit Majumdar
Grants (2015-)
Grants and contracts awarded during October - December 2025.
